rs2227284 — IL4 IL4 T+2979G

Intronic regulatory variant in IL-4, the master Th2 cytokine; the T allele impairs IL-4 transcriptional regulation, elevating Th2-skewed inflammatory tone and increasing susceptibility to asthma, allergic rhinitis, and severe infections, while the G allele is associated with reduced atopic disease risk

See your personal result for IL4

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

IL4 T+2979G — The Th2 Dimmer Switch in Intron 3

Interleukin-4 is the master architect of the Th2 immune response. It drives B cells to class-switch from IgM to IgE11 IgE
Immunoglobulin E — the antibody class responsible for allergic reactions; IgE binds mast cells and basophils, which explode with histamine upon allergen encounter, steers naive T cells toward the Th2 fate that underlies atopic disease, and suppresses the Th1 arm of immunity that fights intracellular pathogens. A variant in intron 3 of the IL4 gene — rs2227284, historically designated T+2979G — alters the regulatory machinery controlling IL-4 transcription. The T allele is associated with elevated susceptibility to asthma, allergic rhinitis, and severe bacterial infections; the G allele with relative protection across multiple independent study populations.

The Mechanism

rs2227284 sits within intron 3 of IL4 on chromosome 5q31.1. It does not change the IL-4 protein sequence. Instead, it lies in a region that influences IL-4 transcriptional regulation — a stretch of intronic sequence long suspected to be part of the gene's locus control region, the same genomic neighborhood that contains the IL4 intron 3 variable number tandem repeat (VNTR)22 variable number tandem repeat (VNTR)
A repeated DNA motif (RP1 repeat) whose copy number varies between individuals and has been associated with IL-4 production levels; rs2227284 is in strong linkage disequilibrium with the VNTR haplotype in many populations. The strongest statistical link to phenotype is through IgE regulation: a Polish pediatric cohort33 Polish pediatric cohort
177 asthmatic children versus 194 controls, examining IL4, IL4R, and IL13 variants found that rs2227284 had the most significant association with total IgE levels of any IL4 variant tested (p=0.00047) — a compelling fingerprint that this intronic position modulates IL-4 transcriptional output rather than protein function.

The directionality across populations is consistent: the T allele (GRCh38 plus-strand reference, but the rarer allele in Europeans at ~29% frequency) associates with elevated atopic disease risk and higher IgE, while the G allele (major in Europeans at ~71%) is associated with lower risk. Ethnically, G allele frequency varies enormously — ~71% in Europeans, ~64% in South Asians, ~40% globally, ~16% in East Asians and ~9% in Africans — which explains why directional effects can differ across study populations.

The Evidence

In a study of 393 Japanese women with rhinoconjunctivitis and 703 controls44 393 Japanese women with rhinoconjunctivitis and 703 controls
Kyushu Okinawa Maternal and Child Health Study cohort, using ISAAC criteria for rhinoconjunctivitis definition, the GG genotype at rs2227284 was significantly inversely associated with rhinoconjunctivitis compared with TT (adjusted OR 0.60, 95% CI 0.37–0.98). The protective effect was confined to never-smokers — an important interaction suggesting that smoking, which independently dysregulates IL-4 signaling, can override the genotype's protective direction.

In 503 Chinese Han children with allergic rhinitis and 393 controls55 503 Chinese Han children with allergic rhinitis and 393 controls
a GWAS-loci validation study examining 16 candidate SNPs in childhood AR, the TG genotype was associated with a 0.65-fold decreased risk of AR compared with TT. A C-G-C haplotype spanning rs2243250–rs2227284–rs2243290 was protective, placing the G allele as part of the low-risk regulatory haplotype.

Among 214 Pakistani patients (108 asthma, 106 allergic rhinitis) versus 120 healthy controls66 214 Pakistani patients (108 asthma, 106 allergic rhinitis) versus 120 healthy controls
cross-sectional study examining three IL4 intronic SNPs, rs2227284 showed significant associations with both asthma (chi-square 22.51, p<0.001) and allergic rhinitis (chi-square 57.6, p<0.001) — the strongest p-values among all three IL4 variants studied. A Chinese pediatric study77 Chinese pediatric study
392 asthmatic children and 849 controls examining both IL-2 and IL-4 polymorphisms confirmed that rs2227284 was associated with reduced asthma risk in both heterozygotes (p=0.026) and G-allele homozygotes (p=0.001).

Beyond atopy, the variant's immunological reach extends to infection severity. A study of 57 adult pneumococcal pneumonia patients and 280 controls88 study of 57 adult pneumococcal pneumonia patients and 280 controls
focused on host genetics and P-CAP susceptibility and severity found IL4 rs2227284 associated with severe pneumococcal community-acquired pneumonia (OR 2.17, p=0.04), consistent with the T allele's effect on Th2 immune polarization impairing Th1-dependent antibacterial clearance. A 2024 Chinese RA study (n=986) additionally found the G allele protective against rheumatoid arthritis development, adding autoimmune susceptibility to the variant's phenotypic repertoire.

Practical Actions

For TT homozygotes — who carry both T alleles and sit at highest risk — the primary value of knowing this genotype is heightened awareness of atopic disease progression. The T allele's clearest clinical signal is in individuals who are already atopically sensitized: if you have eczema, allergic rhinitis, or food allergy, the elevated IL-4 regulatory output at the rs2227284 locus amplifies your risk of asthma development (the atopic march). Monitoring total IgE and seeking early allergist evaluation are the most direct responses.

The smoking interaction documented in the rhinoconjunctivitis data is clinically significant for TG heterozygotes: the G allele's protective effect was abolished in ever-smokers. This means the partial protection the G allele confers is contingent on avoiding tobacco exposure.

For all T-allele carriers, antihistamines and corticosteroid nasal sprays treat symptoms; allergen immunotherapy addresses the underlying Th2-skewing mechanism by redirecting the immune response toward Th1/Treg tolerance and, in doing so, directly opposes the mechanism this variant amplifies.

Interactions

rs2243250 (C-589T, promoter), rs2070874 (C-33T), and rs2243290 are the other major IL4 SNPs studied alongside rs2227284. They form haplotypes that collectively determine IL-4 expression level; rs2243250 is typically the strongest individual signal in promoter-focused studies. rs2227284 and rs2243250 travel together in the protective C-G haplotype (rs2243250 C + rs2227284 G) documented in East Asian cohorts.

rs7130588 (LRRC32/11q13.5) and rs1805011 (IL4Rα I50V) are pathway partners — LRRC32 controls Treg-mediated TGF-β tolerance, and IL4Rα rs1805011 controls IL-4 receptor signaling downstream of IL-4 binding. Carrying risk alleles at multiple nodes of the IL-4/Th2 axis (IL4 production at rs2227284, receptor sensitivity at rs1805011, and Treg tolerance at rs7130588) may cumulatively define the highest-risk atopic phenotype, though formal compound analyses of this exact combination remain unpublished.

Genotype Interpretations

What each possible genotype means for this variant.

GG Protective Genotype Normal

Two copies of the G allele — the common, lower-risk genotype associated with reduced atopic disease susceptibility

You carry two copies of the G allele at rs2227284 — the population-major and protective genotype. In European populations, approximately 51% of people share this homozygous genotype. The G allele is associated with more regulated IL-4 transcriptional output at this intronic locus, and across multiple study populations the GG genotype is consistently the least frequent among atopic disease cases. A Japanese cohort found GG homozygotes had 60% lower odds of rhinoconjunctivitis compared with TT carriers; Chinese pediatric data show the G allele associated with significantly reduced asthma risk. Your IL4 rs2227284 genotype does not contribute to elevated atopic disease susceptibility.

GT One Risk Allele Intermediate

One copy of the T risk allele — modestly elevated atopic disease susceptibility through altered IL-4 regulation

The TG heterozygous state represents an intermediate IL-4 regulatory phenotype. While the G allele's protective direction is present — and TG genotypes consistently show intermediate disease rates between TT and GG in atopic cohorts — the effect size per allele is modest. The variant's most robust phenotypic link is to total IgE levels (p=0.00047 in a pediatric asthma cohort), suggesting that even one T allele may nudge IgE production slightly upward. The strongest risk context for T-allele carriers is existing atopic sensitization: if you already have eczema, food allergy, or allergic rhinitis, the elevated IL-4 tone at this locus amplifies atopic march risk (progression to asthma).

TT Two Risk Alleles High Risk

Two copies of the T risk allele — elevated susceptibility to atopic disease, higher IgE production, and augmented Th2-skewed inflammatory tone

The TT genotype places you at the highest-risk end of the IL4 rs2227284 spectrum. IL-4 is the pivot point of Th2 immunity: it instructs B cells to class-switch antibody production to IgE (enabling allergic sensitization), promotes further Th2 differentiation (amplifying the atopic phenotype), suppresses Th1 responses (impairing clearance of intracellular pathogens and certain bacteria), and signals through the IL-4Rα/γc receptor complex on airway epithelial cells (contributing to mucus hypersecretion in asthma). When IL-4 transcriptional regulation is dysregulated toward higher output, all of these downstream consequences are amplified.

The clinical breadth of the T-allele risk covers the atopic triad (allergic rhinitis, atopic asthma, atopic dermatitis), extends to infection susceptibility (OR 2.17 for severe pneumococcal pneumonia), and reaches into autoimmune susceptibility (protective effect of G allele against RA in Chinese cohort data). The common thread is that elevated IL-4 tone biases adaptive immunity toward Th2 polarization at the expense of Th1 and Treg-mediated balance — a shift that promotes allergy, impairs certain antimicrobial defenses, and may alter autoimmune thresholds.

Smoking critically interacts with this locus: the G allele's protective effect was abolished in ever-smokers in the Japanese rhinoconjunctivitis study, suggesting tobacco exposure saturates IL-4 pathway dysregulation such that the T/G genotype no longer meaningfully differentiates risk. For TT carriers, avoidance of tobacco is especially important because there is no G-allele partial protection to preserve.